Teva Loses Bid To Invalidate Astellas Incontinence Drug Patent
Japanese pharma giant Astellas has defeated attempts by two rival drugmakers to revoke its patent for treating urinary problems, as a judge rejected claims on Wednesday that the invention would have...To view the full article, register now.
Already a subscriber? Click here to view full article